Research Article
Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices
Table 2
Clinicopathologic characteristics of 40 patients with NSCLC.
| | Characteristics | Descriptive |
| | Age () | | | Median | 59.5 y | | Sex (male/female) | 25/15 | | Smoking | | | Never smoker | 17 (42.5%) | | Current smoker | 11 (27.5%) | | Past smoker | 12 (30%) | | ECOG-PS | | | 12 (30%) | | 13 (32.5%) | | 15 (37.5%) | | Histopathology | | | Squamous cell carcinoma | 12 (30%) | | Adenocarcinoma | 23 (57.5%) | | Large cell carcinoma | 4 (10%) | | Bronchoalveolar carcinoma | 1 (2.5%) | | Stage | | | IIIA | 9 (22.5%) | | IIIB | 14 (35%) | | IV | 17 (42.5%) | | Median number of chemotherapy cycles | 3 (range: 0–7) | | LMR () | | | MPV/PC ratio () | | | Relative monocytic count | | | Relative lymphocytic count | | | Outcome | | | Dead | 26 (65%) | | Alive | 14 (35%) |
|
|
LMR: lymphocyte to monocyte ratio; MPV/PC ratio: mean platelet volume to platelet count ratio; ECOG-PS: Eastern Cooperative Oncology Group-performance status.
|
